LIBI-Diagnostics

Cancer Diagnostic Test

Health Tech & Life Sciences
Active
Pre-Funding Haifa, Israel Founded 2020
Last updated 2026-06-18
Total raised
Last: 2021-10
Stage
Pre-Funding
Founded
2020
Headcount
6
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

LIBI Diagnostics is a gene-biomarker start-up for the early detection of cancer, powered by next-generation bio-liquid tests.

Using state-of-the-art Next-Generation Sequencing (NGS) technology, LIBI-Diagnostics customizing tests for each patient by detecting alterations of Aurora Kinase A in blood and/or voided urine samples compared to the genomic expression data in the primary tumor.

Libi-Diagnostics provides a practical and effective answer to the the inefficiency of periodic imaging tests. LIBI diagnoses recurrent cancerous development in an early stage with only few cells and provides sufficient information to neutralize that early development. In this way, it is possible to spare the patient aggressive treatments, unnecessary suffering and maintain his good chances of survival.

Funding history · 1 round · — total

2021-10

Q&A

What is LIBI-Diagnostics' primary focus?
LIBI-Diagnostics is a gene-biomarker startup focused on the early detection of cancer using next-generation bio-liquid tests.
When was LIBI-Diagnostics founded?
LIBI-Diagnostics was founded in January 2020.
How many employees does LIBI-Diagnostics have?
LIBI-Diagnostics has 1-10 employees.
What technology does LIBI-Diagnostics utilize for its diagnostic tests?
LIBI-Diagnostics uses Next-Generation Sequencing (NGS) technology to detect alterations of Aurora Kinase A in blood and/or voided urine samples for cancer diagnosis.
Who are the co-founders of LIBI-Diagnostics?
The co-founders of LIBI-Diagnostics are David Risin, who serves as Co-Founder & CEO, and Dr. Ayelet Ben Barak, who is Co-founder & CMO.
What is the current stage of LIBI-Diagnostics' product development?
LIBI-Diagnostics' product is currently in the R&D stage.
What was LIBI-Diagnostics' last funding round?
In October 2021, LIBI-Diagnostics received $100,000 in a funding round led by Headstart.

Team · 2

Founder · Co-Founder & CEO
LinkedIn ↗
Founder · Co-founder & CMO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B

Tags

cancerdiagnosticsoncologygeneticspatientsearly-detectiondoctorsnon-invasivebiomarkersdigital-healthcare
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)